Read stories from patients who have received treatment and care at the OSUCCC – James.
Several OSUCCC – James clinical trial patients have generously offered to share their personal cancer treatment stories, with the hope of providing insight, wisdom and strength to other survivors and their caregivers.
Learn more about the experiences people have had at OSUCCC – James by reading stories about our cancer patients and volunteers.
Being diagnosed with metastatic breast cancer at age 32, Carolyn Kerr joined a clinical trial. Her hope was not only to have a chance to try the newest medications, but to add to the study results.
Thanks to a clinical trial at the OSUCCC — James, Rick Walker survived pancreatic cancer, an extremely aggressive disease. Only about 12% of people with pancreatic cancer, on average, are alive five or more years after they’re diagnosed.
Brian Koffman was fighting an aggressive form of CLL that was proving difficult to treat until he found the OSUCCC – James, where he was enrolled him in an ibrutinib clinical trial that saved his life.
Having just been diagnosed with a blood cancer without a cure, Deirdre pursued treatment at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
A former statistician at The Ohio State University, Donn Young was diagnosed with an advanced form of prostate cancer near his 60th birthday. He credits his continued survival to a clinical trial at the OSUCCC – James.
After discovering she had triple-negative breast cancer, Gerri Speer was offered hope by enrolling in a clinical trial for patients with aggressive breast cancer.
Gesele Booker says that a personal breast cancer diagnosis always felt inevitable. She had watched several women in her family navigate diagnosis and treatment choices, ultimately losing her mother to the disease in 2018.
After undergoing tests, Guy Fisher was diagnosed first with early‐stage multiple myeloma, then a few months later with AL amyloidosis. Both are rare diseases.
Colon cancer survivor Jay McDaniel participated in an immunotherapy clinical trial that saved his life. He was astonished at how differently he felt on immunotherapy compared to chemotherapy.
Jim Bicak witnessed first-hand the benefits of taking part in a clinical trial at the OSUCCC – James.
After a variety of cancer treatments, Laura Dixon credits an immunotherapy clinical trial at the OSUCCC – James for saving her life.
When Lynn Aspey was diagnosed with small lymphocytic lymphoma, she was enrolled in a clinical trial for high-risk SLL patients.
Diagnosed with mantle cell lymphoma, Lynn Malone found strength in faith and family support, achieving remission through a clinical trial at OSUCCC – James.
Patricia Smith is a private person, but when it comes to the exceptional care she has received from David O’Malley, MD, at the OSUCCC – James, she can’t say enough.
Phillip Morrow credits a clinical trial for giving him a new outlook on life with lung cancer.
Taking part in a clinical trial testing a new oral drug called acalabrutinib was a game-changer for Robert Bowen's cancer treatment.
Robyn Stacy-Humphries joined an OSUCCC – James CAR-T clinical trial in 2015 and is currently in remission for diffuse large B-cell lymphoma.
Ronald Staab Jr. of Westerville, Ohio, can’t say with certainty whether participating in a clinical trial after his kidney cancer treatment will have lasting benefit, but so far so good.
After joining a CAR-T clinical trial at the OSUCCC – James, Steve Fulkert's B-cell lymphoma is in remission and he "feels wonderful."
Sharing is what Tracy Palmer is about, from bringing her children to chemotherapy sessions to ease their minds to enrolling in not one but five clinical trials at the OSUCCC – James.
A successful clinical trial experience has kept Wally Yocum’s CLL at bay. Now he speaks openly to others about his experience and encourages everyone to participate in clinical trials.